IMPORTANCE: The rabies virus causes a fatal encephalitis and can be transmitted through tissue or organ transplantation. In February 2013, a kidney recipient with no reported exposures to potentially rabid animals died from rabies 18 months after transplantation. OBJECTIVES: To investigate whether organ transplantation was the source of rabies virus exposure in the kidney recipient, and to evaluate for and prevent rabies in other transplant recipients from the same donor. DESIGN: Organ donor and all transplant recipient medical records were reviewed. Laboratory tests to detect rabies virus-specific binding antibodies, rabies virus neutralizing antibodies, and rabies virus antigens were conducted on available specimens, including serum, cerebrospinal fluid, and tissues from the donor and the recipients. Viral ribonucleic acid was extracted from tissues and amplified for nucleoprotein gene sequencing for phylogenetic comparisons. MAIN OUTCOMES AND MEASURES: Determination of whether the donor died from undiagnosed rabies and whether other organ recipients developed rabies. RESULTS: In retrospect, the donor's clinical presentation (which began with vomiting and upper extremity paresthesias and progressed to fever, seizures, dysphagia, autonomic dysfunction, and brain death) was consistent with rabies. Rabies virus antigen was detected in archived autopsy brain tissue collected from the donor. The rabies viruses infecting the donor and the deceased kidney recipient were consistent with the raccoon rabies virus variant and were more than 99.9% identical across the entire N gene (1349/1350 nucleotides), thus confirming organ transplantation as the route of transmission. The 3 other organ recipients remained asymptomatic, with rabies virus neutralizing antibodies detected in their serum after completion of postexposure prophylaxis (range, 0.3-40.8 IU/mL). CONCLUSIONS AND RELEVANCE: Unlike the 2 previous clusters of rabies virus transmission through solid organ transplantation, there was a long incubation period in the recipient who developed rabies, and survival of 3 other recipients without pretransplant rabies vaccination. Rabies should be considered in patients with acute progressive encephalitis of unexplained etiology, especially for potential organ donors. A standard evaluation of potential donors who meet screening criteria for infectious encephalitis should be considered, and risks and benefits for recipients of organs from these donors should be evaluated.
IMPORTANCE: The rabies virus causes a fatal encephalitis and can be transmitted through tissue or organ transplantation. In February 2013, a kidney recipient with no reported exposures to potentially rabid animals died from rabies 18 months after transplantation. OBJECTIVES: To investigate whether organ transplantation was the source of rabies virus exposure in the kidney recipient, and to evaluate for and prevent rabies in other transplant recipients from the same donor. DESIGN: Organ donor and all transplant recipient medical records were reviewed. Laboratory tests to detect rabies virus-specific binding antibodies, rabies virus neutralizing antibodies, and rabies virus antigens were conducted on available specimens, including serum, cerebrospinal fluid, and tissues from the donor and the recipients. Viral ribonucleic acid was extracted from tissues and amplified for nucleoprotein gene sequencing for phylogenetic comparisons. MAIN OUTCOMES AND MEASURES: Determination of whether the donor died from undiagnosed rabies and whether other organ recipients developed rabies. RESULTS: In retrospect, the donor's clinical presentation (which began with vomiting and upper extremity paresthesias and progressed to fever, seizures, dysphagia, autonomic dysfunction, and brain death) was consistent with rabies. Rabies virus antigen was detected in archived autopsy brain tissue collected from the donor. The rabies viruses infecting the donor and the deceased kidney recipient were consistent with the raccoonrabies virus variant and were more than 99.9% identical across the entire N gene (1349/1350 nucleotides), thus confirming organ transplantation as the route of transmission. The 3 other organ recipients remained asymptomatic, with rabies virus neutralizing antibodies detected in their serum after completion of postexposure prophylaxis (range, 0.3-40.8 IU/mL). CONCLUSIONS AND RELEVANCE: Unlike the 2 previous clusters of rabies virus transmission through solid organ transplantation, there was a long incubation period in the recipient who developed rabies, and survival of 3 other recipients without pretransplant rabies vaccination. Rabies should be considered in patients with acute progressive encephalitis of unexplained etiology, especially for potential organ donors. A standard evaluation of potential donors who meet screening criteria for infectious encephalitis should be considered, and risks and benefits for recipients of organs from these donors should be evaluated.
Authors: Staci A Fischer; Mary Beth Graham; Matthew J Kuehnert; Camille N Kotton; Arjun Srinivasan; Francisco M Marty; James A Comer; Jeannette Guarner; Christopher D Paddock; Dawn L DeMeo; Wun-Ju Shieh; Bobbie R Erickson; Utpala Bandy; Alfred DeMaria; Jeffrey P Davis; Francis L Delmonico; Boris Pavlin; Anna Likos; Martin J Vincent; Tara K Sealy; Cynthia S Goldsmith; Daniel B Jernigan; Pierre E Rollin; Michelle M Packard; Mitesh Patel; Courtney Rowland; Rita F Helfand; Stuart T Nichol; Jay A Fishman; Thomas Ksiazek; Sherif R Zaki Journal: N Engl J Med Date: 2006-05-25 Impact factor: 91.245
Authors: R Rodríguez-Romo; L E Morales-Buenrostro; L Lecuona; N Escalante-Santillán; A Velasco-Villa; I Kuzmin; C E Rupprecht; C De-Leo; J Ramírez; J Alberú Journal: Transpl Infect Dis Date: 2011-08-26 Impact factor: 2.228
Authors: T Maier; A Schwarting; D Mauer; R S Ross; A Martens; V Kliem; J Wahl; M Panning; S Baumgarte; T Müller; S Pfefferle; H Ebel; J Schmidt; K Tenner-Racz; P Racz; M Schmid; M Strüber; B Wolters; D Gotthardt; F Bitz; L Frisch; N Pfeiffer; H Fickenscher; P Sauer; C E Rupprecht; M Roggendorf; A Haverich; P Galle; J Hoyer; C Drosten Journal: Clin Infect Dis Date: 2010-04-15 Impact factor: 9.079
Authors: Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala Journal: Rev Bras Ter Intensiva Date: 2016-09
Authors: N M Vora; L A Orciari; M Niezgoda; G Selvaggi; V Stosor; G M Lyon; R M Wallace; J Gabel; D R Stanek; P Jenkins; M Shiferaw; P Yager; F Jackson; C A Hanlon; I Damon; J D Blanton; S Recuenco; R Franka Journal: Transpl Infect Dis Date: 2015-05-19 Impact factor: 2.228
Authors: Lisa M McElroy; Amna Daud; Brittany Lapin; Olivia Ross; Donna M Woods; Anton I Skaro; Jane L Holl; Daniela P Ladner Journal: Surgery Date: 2014-10-17 Impact factor: 3.982
Authors: Stephanie M Pouch; Shalika B Katugaha; Wun-Ju Shieh; Pallavi Annambhotla; William L Walker; Sridhar V Basavaraju; Jefferson Jones; Thanhthao Huynh; Sarah Reagan-Steiner; Julu Bhatnagar; Kacie Grimm; Susan L Stramer; Julie Gabel; G Marshall Lyon; Aneesh K Mehta; Prem Kandiah; David C Neujahr; Jeffrey Javidfar; Ram M Subramanian; Samir M Parekh; Palak Shah; Lauren Cooper; Mitchell A Psotka; Rachel Radcliffe; Carl Williams; Sherif R Zaki; J Erin Staples; Marc Fischer; Amanda J Panella; Robert S Lanciotti; Janeen J Laven; Olga Kosoy; Ingrid B Rabe; Carolyn V Gould Journal: Clin Infect Dis Date: 2019-07-18 Impact factor: 9.079
Authors: Micaela De la Puente-León; Michael Z Levy; Amparo M Toledo; Sergio Recuenco; Julianna Shinnick; Ricardo Castillo-Neyra Journal: Am J Trop Med Hyg Date: 2020-09 Impact factor: 2.345